Modulation of immunoglobulin production by invariant Vα19-Jα33 TCR-bearing cells.
We have previously shown that invariant Vα19-Jα33 TCR(+) (Vα19i T) cells suppress the disease progress in some models for organ specific autoimmune diseases and type IV allergy that deteriorate along with decline to excess in Th1- or Th17- immunity. In this study, we examined the effects of over-gen...
Guardado en:
Autores principales: | Michio Shimamura, Yi-Ying Huang, Hiroshi Hidaka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20e876d704484c12bc20225af42cee97 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data
por: Alessandro Montemurro, et al.
Publicado: (2021) -
Safety evaluation of the mouse TCRα - transduced T cell product in preclinical models in vivo and in vitro
por: Anastasiia Kalinina, et al.
Publicado: (2022) -
The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
por: Akul Singhania, et al.
Publicado: (2021) -
TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF⁺ leukocytes.
por: Kirsten Reichwald, et al.
Publicado: (2014) -
Unbiased analysis of TCRα/β chains at the single-cell level in human CD8+ T-cell subsets.
por: Xiaoming Sun, et al.
Publicado: (2012)